Can-Fite BioPharma (CANF) Interest Expenses (2014 - 2019)

Can-Fite BioPharma (CANF) has 6 years of Interest Expenses data on file, last reported at $537000.0 in Q4 2019.

• For the quarter ending Q4 2019, Interest Expenses rose 20.4% year-over-year to $537000.0; the trailing twelve-month figure through Dec 2019 stood at $29000.0 (up 61.11% YoY), and the FY2025 full-year result was $36000.0, down 60.0% from the prior year.
• Interest Expenses was $537000.0 for Q4 2019 at Can-Fite BioPharma, up from -$519000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $972000.0 in Q3 2015 to a low of -$1.9 million in Q4 2017.
• A 5-year average of -$87100.0 and a median of -$6500.0 in 2015 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses soared 9450.0% in 2016 and tumbled 532.93% in 2019, its largest moves.
• Can-Fite BioPharma's Interest Expenses stood at -$1.1 million in 2015, then soared by 37.25% to -$694000.0 in 2016, then sank by 172.48% to -$1.9 million in 2017, then surged by 123.59% to $446000.0 in 2018, then increased by 20.4% to $537000.0 in 2019.
• Per Business Quant data, the three most recent Interest Expenses figures were $537000.0 in Q4 2019, -$519000.0 in Q3 2019, and -$119000.0 in Q2 2019.